Zhibin Liu

No ORCID on file · 2 papers in corpus
nonrandomized-trial 2025
Scientific reports ·doi:10.1038/s41598-025-22880-9

Levonorgestrel intrauterine-releasing system (LNG-IUS), an intrauterine device, is recommended for patients with adenomyosis; however, it often shows poor outcomes in these patients because of their large uterine size. This prospective stud…

lab-animal 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01846-5

BACKGROUND: Hydroxyurea (HU) is an antitumor drug. However, HU exposure is associated with diminished ovarian reserve (DOR). Zi Chong granules, a Chinese Medicine, can protect against DOR, but little is known regarding its underlying mechan…